SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : LSI Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sea_biscuit who wrote (18901)6/15/1999 6:29:00 PM
From: shane forbes  Read Replies (2) of 25814
 
Care to give me an example? I'd like to see what exactly is going
on here.

Here's the data:

Buy 200 shares at $10.

Sell 100 shares at $25.

As you calculate it, what is the cost basis of the remaining 100 shares? Is it -5 or something else? Again ignore commissions and taxes here. -5 would be the same as my Method 1.

(Profit is 1500. Remove 1500 from 1000 giving -500. -500 divided by 100 remaining shares is -5. Again the only way you'll be up is if you have a -ve number left over. I should modify this a bit. If the current price is above your new cost basis you still have an unrealized profit if the price of the stock is above your new cost basis.)

-- ending song: Repeat 17--

'The base revenues for LSI were $1.85 billion in 1998. Except for a IPR&D accounting
writeoff (bogus), the Symbios assets that LSI bought were not subsequently written off.
What did take place was a $5.4 million Symbios Integration Accrual. Per the 10-K,
page 42, this accrual comprised '$4 million related to involuntary separation and
relocation benefits for approximately 300 Symbios positions and $1.4 million in other
exit costs primarily relating to the closing of Symbios sales offices and the termination of
certain contractual relationships.' Therefore it appears that the $75 mil restructuring
charge taken later was for the 'old LSI' and has very little negative bearing on Symbios
continuing operations. LSI valued Symbios at a fair value of $804 million - $324 million
for tangible assets, $214 million for current technology, $37 million for assembled
workforce and trademarks, $83 million for goodwill, and $146 million for IPR&D (this
part was written off). In this context, $5.4 million is puny and irrelevant. Symbios' assets
(read: ability to generate revenue) only strengthened after integration with LSI. They did
not weaken. Further, LSI has not indicated that they discontinued anything significant in
the Symbios product line. Because they used purchase accounting (versus pooling) LSI
can't use pro-forma Q1, Q2, Q3 or
full-year 1998 numbers going forward. It is NOT because, as Jock mumbles
grandiosely: "It would be a terrible disservice to the company, shareholders, and the
public in general.". Give me a freakin' break.'

---

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext